Major depressive disorder (MDD) is a disabling medical condition associated with significant morbidity, mortality and public health costs. However, neurocircuitry abnormalities underlying depression remain incompletely understood and consequently current treatment options are unfortunately limited in efficacy. Recent research has begun to focus specifically on cognitive aspects of depression and potential neurobiological correlates. Two fundamental types of cognitive dysfunction observed in MDD are cognitive biases, which include distorted information processing or attentional allocation toward negative stimuli, and cognitive deficits, which include impairments in attention, short-term memory and executive functioning. In this article, we present a selective review of current research findings in these domains and examine neuroimaging research that is beginning to characterize the neurocircuitry underlying these biases and deficits. We propose that deficient cognitive functioning, attention biases and the sustained negative affect characteristic of MDD can be understood as arising in part from dysfunctional prefrontal-subcortical circuitry and related disturbances in the cognitive control of emotion. Finally, we highlight potential new pharmacological and non-pharmacological therapeutic strategies for MDD based on an evolving mechanistic understanding of the disorder.

Original languageEnglish
Pages (from-to)553-563
Number of pages11
JournalNeurobiology of Learning and Memory
Issue number4
StatePublished - Nov 2011


  • Cognition
  • Cognitive dysfunction
  • Depression
  • Emotion regulation
  • Neuroimaging
  • Neuropsychology
  • Therapeutics


Dive into the research topics of 'Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies'. Together they form a unique fingerprint.

Cite this